1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > In vitro Fertilization Devices and Consumables Market - Opportunities and Forecasts, 2014 - 2020

In vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is a widely popular treatment, adopted by couples with infertility problems, single mothers, and the LGBT community to procreate.The world in vitro fertilization devices and consumables market is projected to garner $3,025.2 mllion by 2020, registering a CAGR of 19.7% over the forecast period. The world IVF devices & consumables market is growing significantly owing to rising incidences of infertility, developments in IVF procedures, and growing healthcare expenditures. Furthermore, the rising awareness about infertility and easy availability of IVF treatments, would drive the market growth. Recent technological innovations in the IVF technology, such as embryoscope and capsule IVF, are expected to drive the demand for IVF devices and consumables in future. However, strenuous maintenance issues and inherent high cost associated with the devices limit the growth of the market. The shift in adoption of conventional infertility treatments such as infertility-medication (clomid), to the advanced IVF technologies would boost numerous growth opportunities for the IVF devices market. However, unaffordability of high-end IVF devices is the major challenge faced by local IVF clinics.The world IVF devices market is segmented into IVF devices, reagent & media, techniques, end users, and geography. The devices considered in this report include sperm separation system, cryosystem, incubator, imaging system, ovum aspiration pump, IVF cabinet, micromanipulator, and IVF-accessories & disposables among others. The capital equipment set up is the fastest growing segment owing to the increasing number of newly established IVF centers. However, disposables and consumables used during IVF procedures are the highest revenue generating segments.Based on reagents & media, the market is categorized into, cryopreservation media, semen processing media, ovum processing media and embryo culture media. Cryopreservation media is the highest revenue generating segment owing to its large application during frozen IVF cycles. IVF devices and consumables market by techniques is categorized into, fresh embryo IVF, frozen egg IVF and donor egg IVF. Fresh embryo IVF cycles is the largest revenue generating segment, owing to growing number of couples opting for fresh IVF cycles. The world IVF devices market by end-users is segmented into clinics, hospitals, surgical centres and clinical research institutes. Fertility clinic is the highest revenue generating segment, owing to short patient wait time and higher success rate.The world IVF devices market is analysed on the basis of geographical regions into North America, Europe, Asia-Pacific, and LAMEA. North America and Europe are the leading revenue generating regions, collectively accounted for about 80% of the market share in 2015. However, the Asia-Pacific region would be the fastest growing region, owing to the high demand for economic IVF services and availability of skilled workforce.Product launch is one of the key strategies adopted by prominent players in the IVF devices and consumables market for the launch of micromanipulators systems, ovum aspiration pumps and IVF accessories among others. These technologies are used in both clinical and research fields. Companies profiled in this report include Vitrolife AB, EMD Serono, Inc., Irvine Scientific, CooperSurgical, Inc., Cook Medical, Inc., Thermo Fisher Scientific, Inc., Genea Biomedx, Auxogyn, Inc., Oxford Gene Technology, and OvaScience Inc.KEY MARKET BENEFITSAn in-depth analysis of current research and clinical developments within world IVF devices market is provided with key market dynamic factors that help in understanding the behavior of market.The report provides quantitative analysis of the current market and estimations through 2014-2020, which assists in identifying the prevailing market opportunities.A comprehensive analysis of the market scenario in terms of devices, accessories & disposables and reagents & media helps in identifying the prevailing opportunities in the world IVF devices & consumables market.An in-depth analysis of current research and developments in the world IVF devices and consumables market provides key market dynamic factors shapes the market dynamics.Geographically, the world IVF devices and consumables market is analyzed based on various regions such as North America, Europe, Asia-Pacific, and LAMEA.Competitive intelligence (of leading manufacturers and distributors of IVF devices) highlights the business practices followed by leading market players across the geographies.SWOT analysis enables to study the internal environment of prominent companies for strategy formulation.Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders.IN VITRO FERTILIZATION DEVICES AND CONSUMABLES MARKET KEY SEGMENTS:The world IVF devices market is segmented on the basis of instruments, reagents & media, techniques, end users, and geography.By DeviceSperm Separation SystemCryosystemIncubatorsImaging SystemOvum Aspiration PumpCabinetMicromanipulator systemAccessories and DisposablesOthersBy Reagents & MediaCryopreservation MediaSemen Processing MediaOvum Processing MediaEmbryo Culture MediaBy TechniqueFresh Embryo IVFFrozen Egg IVFDonor Egg IVFBy End UserClinicsHospitalsSurgical CentresClinical Research InstitutesBy GeographyNorth AmericaUnited StatesCanadaMexicoEuropeFranceGermanyUnited KingdomOther EuropeAsia-PacificChinaIndiaJapanAustraliaOthersLAMEALatin AmericaThe Middle EastAfrica

Table Of Contents

In vitro Fertilization Devices and Consumables Market - Opportunities and Forecasts, 2014 - 2020
CHAPTER 1 INTRODUCTION1.1 Report description1.2 Key market benefits1.3 Key market segments1.4 Key audiences1.5 Research methodology1.1.1 Secondary research1.1.2 Primary research1.1.3 Analyst tools and modelsCHAPTER 2 EXECUTIVE SUMMARYCHAPTER 3 GLOBAL IVF DEVICES andamp; CONSUMABLES MARKET OVERVIEW3.1 Market definition and scope3.2 Alternative technologies3.2.1 Intrauterine Insemination (IUI) Technique3.2.1.1 Factors assessed for the procedure3.2.1.2 Benefits of this technique3.2.1.3 Risks3.2.2 Difference between IUI and IVF technique3.2.3 GIFT technique3.2.3.1 Difference between GIFT and IVF technique3.2.4 ZIFT technique3.2.4.1 Differences between ZIFT and IVF technique3.3 Replacing IVF procedures by fertility drugs and surgeries3.3.1 Female infertility treatments3.3.1.1 Limitations of fertility drugs3.3.2 Male infertility treatments3.4 Costs related to IVF procedures3.5 Role of donors in the IVF market3.5.1 Egg donation3.5.2 Egg sharing3.5.3 Sperm donation3.5.4 Embryo donation/adoption3.5.5 Donation for research3.6 Surrogacy3.6.1 Legal issues3.7 IVF trends in same sex couples3.7.1 Artificial insemination3.7.2 Surrogate mothers3.7.3 In-vitro fertilization3.8 Advanced IVF technologies3.8.1 Capsule IVF3.8.2 Three parent IVF3.8.2.1 Ethical concerns3.8.3 Mini IVF3.8.3.1 Advantages3.8.3.2 Drawbacks3.8.4 EmbryoScope3.8.4.1 Advantages3.8.5 PICSI3.9 Fertility treatment and gender selection3.9.1 Methods of sex selection3.9.1.1 Gradient method3.9.1.2 Flow cytometry technique3.9.1.3 Pre-implantation genetic diagnosis (PGD)3.9.1.4 Ethical and legal issues3.10 Metabolomics in embryo screening methods3.11 Application of stem cells in IVF3.12 IVF and resource poor countries3.13 Key Findings3.13.1 Top factors impacting3.13.2 Top investment pockets3.13.3 Top winning strategies3.14 Porters five forces analysis3.14.1 High competition and large number reduces the power of suppliers3.14.2 Scattered nature and large count of end users moderates the buyer power3.14.3 High capital cost lowers the threat of new entrants3.14.4 Industry rivalry is intense due to presence of few dominant competitors3.14.5 Lack of efficient substitutes lowers the threat from substitutes3.15 Value chain analysis3.16 Patent analysis3.16.1 Patent analysis by type of patents3.16.2 Patents Analysis by geography3.17 Regulatory issues and legislations3.18 Insurance reimbursement scenario3.19 Clinical trials3.19.1 Trial 1: To study the DHEA outcomes on poor responders of IVF3.19.2 Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome3.19.3 Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation3.19.4 Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment3.19.5 Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures3.20 Drivers3.20.1 Delayed pregnancies in women3.20.2 Rise in global infertility rates3.20.3 Advancement in technology3.20.4 Rise in gamete donations3.20.5 Rise in disposable income3.20.6 Increase in success rates3.21 Restraints3.21.1 Cost constraints3.21.2 Ethical and legal issues3.21.3 Multiple pregnancies3.21.4 Low awareness level3.22 Opportunities3.22.1 Fertility tourism3.22.2 Growing number of fertility clinics3.22.3 Rise in same sex marriagesCHAPTER 4 GLOBAL IVF DEVICES andamp; CONSUMABLES MARKET BY INSTRUMENTS4.1 Global IVF market by instrument, 2014-2020, ($million)4.1.1 Incubators4.1.1.1 Global IVF incubators market by geography4.1.2 Cryosystem4.1.2.1 Global IVF cryosystem market by geography4.1.3 Imaging system4.1.3.1 Global IVF Imaging system market by geography4.1.4 Cabinet (work station)4.1.4.1 Global IVF cabinets market by geography4.1.5 Ovum aspiration pump4.1.5.1 Global IVF ovum aspiration pump market by geography4.1.6 Sperm separation system4.1.6.1 Global IVF Sperm separation system market by geography4.1.7 Micro manipulator system4.1.7.1 Global IVF Micromanipulator market by geography4.1.8 Others4.1.8.1 Global IVF other instruments market by geography4.2 Accessories and disposables4.2.1 Semen analysis chamber4.2.2 Plastic ware4.2.3 Oocyte retrieval needles4.2.4 Miscellaneous disposables4.2.5 Global IVF accessories and disposables market by geographyCHAPTER 5 GLOBAL IVF DEVICES andamp; CONSUMABLES MARKET, BY REAGENTS andamp; MEDIA5.1 Global IVF market by reagents andamp; media, 2014-2020, ($million)5.2 Cryopreservation media5.2.1 Embryo cryopreservation media5.2.2 Sperm cryopreservation media5.2.3 Oocyte cryopreservation media5.2.4 Global IVF cryopreservation media market by geography5.3 Semen processing media5.3.1 Global IVF semen processing media market by geography5.4 Ovum processing media5.4.1 Global IVF ovum processing media market by geography5.5 Embryo culture media5.5.1 Global IVF embryo culture media market by geographyCHAPTER 6 GLOBAL IVF DEVICES andamp; CONSUMABLES MARKET, BY TECHNIQUE6.1 Global IVF market, by technique, 2014-2020 ($Million)6.2 Fresh embryo transfer technique6.2.1 Drivers6.2.1.1 trends of Delayed pregnancies6.2.1.2 Growing rates of infertility6.2.2 Restraints6.2.2.1 Cost involved in the treatment6.2.2.2 reimbursements issues with fresh embryo ivf cycles6.2.3 Global fresh embryo IVF cycle market, by geography6.3 Frozen Embryo Transfer technique (FER)6.3.1 Reasons to use this technique6.3.2 Advantages of Frozen egg IVF technique6.3.3 Disadvantages of frozen egg IVF technique6.3.4 Global frozen egg IVF cycle market, by geography6.4 Donor Egg IVF technique6.4.1 Benefits of donor egg IVF technique6.4.2 Risks associated with donor egg IVF cycle technique6.4.3 Global donor egg IVF cycle market by geographyCHAPTER 7 GLOBAL IVF DEVICES andamp; CONSUMABLES MARKET, BY END USERS7.1 Global IVF market by end user, 2014-2020 ($Million)7.2 Hospitals7.2.1 Global IVF hospitals market by geography7.3 Surgical centers7.4 Clinical research institutes7.4.1 Global IVF clinical research institutes market by geography7.5 Clinics7.5.1 Global IVF Clinics market by geographyCHAPTER 8 GLOBAL IVF DEVICES andamp; CONSUMABLES MARKET, BY GEOGRAPHY8.1 North America8.1.1 North America IVF devices and consumables market, by country8.1.1.1 United States IVF devices and consumables market8.1.1.2 Canada IVF devices and consumables market8.1.1.3 Mexico IVF devices and consumables market8.2 Europe8.2.1 Europe IVF devices and consumables market, by component8.2.1.1 Germany IVF devices and consumables market8.2.1.2 France IVF devices and consumables market8.2.1.3 United Kingdom IVF devices and consumables market8.2.1.4 Other Europe IVF devices and consumables market8.3 Asia-Pacific8.3.1 Asia-Pacific IVF devices andamp; consumables market, by component8.3.1.1 India IVF devices andamp; consumables market8.3.1.2 China IVF devices andamp; consumables market8.3.1.3 Japan IVF devices andamp; consumables market8.3.1.4 Australia IVF devices andamp; consumables market8.3.1.5 other Asia-pacific IVF devices andamp; consumables market8.4 LAMEA8.4.1 LAMEA IVF devices andamp; consumables market, by component8.4.1.1 Latin America IVF devices andamp; consumables market8.4.1.2 Middle East IVF devices andamp; consumables market8.4.1.3 Africa IVF devices andamp; consumables marketCHAPTER 9 COMPANY PROFILE9.1 Vitrolife AB9.1.1 Company overview9.1.2 Business performance9.1.3 Strategic moves and developments9.1.4 SWOT analysis of Vitrolife AB9.2 EMD Serono, Inc.9.2.1 Company overview9.2.2 Business performance9.2.3 Strategic moves and developments9.2.4 SWOT analysis of EMD Serono, Inc.9.3 Irvine Scientific9.3.1 Company overview9.3.2 Business performance9.3.3 Strategic moves and developments9.3.4 SWOT analysis of Irvine scientific9.4 CooperSurgical, Inc. (Origio)9.4.1 Company overview9.4.2 Business performance9.4.3 Strategic moves and developments9.4.4 SWOT analysis of CooperSurgical, Inc.9.5 Cook Medical, Inc.9.5.1 Company overview9.5.2 Strategic moves and developments9.5.3 SWOT analysis of Cook medical, Inc.9.6 Thermo Fisher Scientific Inc.9.6.1 Company overview:9.6.2 Business performance9.6.3 Strategic moves and developments9.6.4 SWOT analysis of Thermo Fisher Scientific, Inc.9.7 Genea Biomedx9.7.1 Company overview9.7.2 Strategic moves and developments9.7.3 SWOT Analysis of Genea Biomedx9.8 Auxogyn, Inc.9.8.1 Company overview9.8.2 Strategic moves and developments9.8.2.1 Primary strategies9.8.2.2 Other strategies9.8.3 SWOT Analysis of Auxogyn, Inc.9.9 Oxford Gene Technology9.9.1 Company overview9.9.2 Strategic moves and developments9.9.3 SWOT analysis of Oxford Gene Technology9.10 Ovascience Inc.9.10.1 Company overview9.10.2 Business performance9.10.3 Strategic moves and developments9.10.4 SWOT analysis of OvaScience, Inc.List of FiguresFIG. 1 IVF DEVICES AND CONSUMABLES MARKET DEFINITIONFIG. 2 ASIA-PACIFIC ADOPTION RATE BY TYPE OF SURROGACYFIG. 3 TOP IMPACTING FACTORS (2014-2020)FIG. 4 TOP INVESTMENT POCKETS OF GLOBAL IVF DEVICES AND CONSUMABLES MARKET (2014-2020)FIG. 5 TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES AND CONSUMABLES MARKET 20122015FIG. 6 TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES AND CONSUMABLES MARKET, 2012-2015FIG. 7 PORTERS FIVE FORCES ANALYSISFIG. 8 VALUE CHAIN ANALYSIS OF GLOBAL IVF MARKETFIG. 9 PATENT ANALYSIS BY TYPE OF PATENTS (2011-2015)FIG. 10 PATENT ANALYSIS BY GEOGRAPHY (2011-2015)FIG. 11 EFFECT OF AGE ON FERTILITYFIG. 12 COMPARISON OF THE MEDIA USED IN EMBRYO CULTUREFIG. 13 SUCCESS RATE OF IVF TECHNIQUES PERFORMED BY AGE, 2013, U.S.FIG. 14 PREGNANCY RATE, PER FROZEN EMBRYO TRANSFER, 2013 (U.S.)FIG. 15 VITROLIFE AB, SALES PER REGION, 2014FIG. 16 VITROLIFE AB, REVENUES ($MILLION), 2012-2014FIG. 17 SWOT ANALYSIS OF VITROLIFE ABFIG. 18 EMD SERONO SALES BY REGION, 2012FIG. 19 SWOT ANALYSIS OF EMD SERONO, INC.FIG. 20 SWOT ANALYSIS OF IRVINE SCIENTIFICFIG. 21 SWOT ANALYSIS OF COOPER SURGICAL, INC.FIG. 22 SWOT ANALYSIS OF COOK MEDICAL, INC.FIG. 23 THERMO FISHER SCIENTIFIC, INC. FINANCIAL REVENUES BY BUSINESS UNITS (2013)FIG. 24 FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2013)FIG. 25 SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC, INC.FIG. 26 SWOT ANALYSIS OF GENEA BIOMEDXFIG. 27 SWOT ANALYSIS OF AUXOGYN, INC.FIG. 28 SWOT ANALYSIS OF OXFORD GENE TECHNOLOGYFIG. 29 SWOT ANALYSIS OF OVASCIENCE, INC.List of TablesTABLE 1 COMPARISON BETWEEN IUI AND IVF PROCEDURESTABLE 2 COMPARISON BETWEEN GIFT AND IVF TECHNOLOGYTABLE 3 COMPARISON BETWEEN ZIFT AND IVF TECHNOLOGYTABLE 4 COST OF DONOR EGG PROCEDURE IN UNITED STATES (2014)TABLE 5 COST OF SPERM DONATION (2014)TABLE 6 AVERAGE SURROGACY COSTS, 2014TABLE 7 COMPARISON BETWEEN TRADITIONAL AND GESTATIONAL SURROGACYTABLE 8 COMPARISON BETWEEN MINI IVF AND CONVENTIONAL IVF TECHNOLOGYTABLE 9 APPLICATIONS OF PGD TECHNOLOGYTABLE 10 PRODUCT LAUNCH AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES AND COMSUMABLES MARKET, 2012-2015TABLE 11 AGREEMENT AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES AND COMSUMABLES MARKET, 20122015TABLE 12 COLLABORATION AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES AND COMSUMABLES MARKET, 2012-2015TABLE 13 INSURANCE COVERAGE FOR COUNTRIESTABLE 14 INFERTILITY RATES IN NORTH AMERICATABLE 15 GLOBAL DISPOSABLE INCOME, 2014-2021TABLE 16 IVF SUCCESS RATES BY AGE, EUROPETABLE 17 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY INSTRUMENT TYPES, 2014-2020 ($MILLION)TABLE 18 TECHNOLOGICAL VARIABLES FOR COMMERCIAL IVF INCUBATORSTABLE 19 GLOBAL IVF INCUBATORS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 20 GLOBAL IVF CRYOSYSTEM MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 21 GLOBAL IVF IMAGING SYSTEM MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 22 GLOBAL IVF CABINETS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 23 GLOBAL IVF OVUM APIRATION PUMP MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 24 MOTILITY OF SPERMS RETRIEVED THROUGH SPERM SEPARATION SYSTEMTABLE 25 GLOBAL IVF SPERM SEPARATION SYSTEM MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 26 GLOBAL IVF MICROMANIPULATOR MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 27 GLOBAL IVF OTHER INSTRUMENTS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 28 GLOBAL IVF ACCESSORIES AND DISPOSABLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 29 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY REAGENTS AND MEDIA TYPES, 2014-2020 ($MILLION)TABLE 30 ADVANTAGES AND DISADVANTAGES OF CRYOPRESERVATION PROCEDURESTABLE 31 CRYOPRESERVATION MEDIA BY VARIOUS COMPANIESTABLE 32 GLOBAL IVF CRYOPRESERVATION MEDIA MARKET , BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 33 COMMERCIALLY AVAILABLE SPERM PROCESSING MEDIA IN THE MARKETTABLE 34 GLOBAL IVF SEMEN PROCESSING MEDIA MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 35 GLOBAL IVF OVUM PROCESSING MEDIA MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 36 EMBRYO CULTURE MEDIA BY VARIOUS COMPANIESTABLE 37 GLOBAL IVF EMBRYO CULTURE MEDIA MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 38 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY TECHNIQUE, 2014-2020 ($MILLION)TABLE 39 GLOBAL FRESH EMBRYO IVF CYCLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 40 COMPARISON BETWEEN FRESH AND FROZEN EMBRYO TRANSFER PROCEDURESTABLE 41 GLOBAL FROZEN EGG IVF CYCLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 42 GLOBAL DONOR EGG IVF CYCLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 43 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY END USERS, 2014-2020 ($MILLION)TABLE 44 GLOBAL IVF HOSPITALS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 45 GLOBAL IVF SURGICAL CENTERS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 46 GLOBAL IVF CLINICAL RESEARCH INSTITUTES MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 47 GLOBAL IVF CLINICS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 48 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY GEOGRAPHY, 20142020 ($MILLION)TABLE 49 REGULATORY SCENARIO, NORTH AMERICATABLE 50 NORTH AMERICA IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 20142020 ($MILLION)TABLE 51 EUROPE IVF CYCLES IN 2014TABLE 52 REGULATORY SCENARIO IN MANUFACTURING OF IVF DEVICES IN EUROPETABLE 53 REGULATORY SCENARIO, EUROPETABLE 54 EUROPE IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 20142020 ($MILLION)TABLE 55 POLICIES BY ASIAN COUNTRIES TO SUPPORT ART TREATMENTTABLE 56 ASIA-PACIFIC IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 20142020 ($MILLION)TABLE 57 TYPE OF DATA COMPONENTS AND THEIR REQUIREMENTSTABLE 58 REGULATORY SCENARIO, LAMEATABLE 59 LAMEA IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 20142020 ($MILLION)TABLE 60 VITROLIFE AB BUSINESS SNAPSHOTTABLE 61 EMD SERONO, INC BUSINESS SNAPSHOTTABLE 62 IRVINE SCIENTIFIC BUSINESS SNAPSHOTTABLE 63 COOPER SURGICAL, INC. BUSINESS SNAPSHOTTABLE 64 COOK MEDICAL, INC. BUSINESS SNAPSHOTTABLE 65 THERMO FISHER SCIENTIFIC INC. BUSINESS SNAPSHOTTABLE 66 GENEA BIOMEDX BUSINESS SNAPSHOTTABLE 67 AUXOGYN, INC. BUSINESS SNAPSHOTTABLE 68 OXFORD GENE TECHNOLOGY BUSINESS SNAPSHOTTABLE 69 OVASCIENCE, INC. BUSINESS SNAPSHOT

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

2016 Competing in the Global Cancer Diagnostics Market

2016 Competing in the Global Cancer Diagnostics Market

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...

Tumor Markers 2020: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

Tumor Markers 2020: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.